US FDA seeks input on orphan product regulation
This article was originally published in Scrip
Executive Summary
The US FDA will hold a public hearing on 29-30 June to gather input from the pharmaceutical industry and other stakeholders about the agency's review and regulation of medical products for orphan diseases.